Symbols / CAH Stock $200.55 -2.13% Cardinal Health, Inc.
CAH (Stock) Chart
About
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Stock Fundamentals
Scroll to Statements| Market Cap | 47.19B | Enterprise Value | 53.63B | Income | 1.66B | Sales | 244.67B | Book/sh | -12.22 | Cash/sh | 11.80 |
| Dividend Yield | 1.02% | Payout | 29.32% | Employees | 53084 | IPO | — | P/E | 28.81 | Forward P/E | 17.31 |
| PEG | 1.36 | P/S | 0.19 | P/B | -16.41 | P/C | — | EV/EBITDA | 14.03 | EV/Sales | 0.22 |
| Quick Ratio | 0.38 | Current Ratio | 0.91 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | 6.96 | EPS next Y | 11.58 |
| EPS Growth | 19.40% | Revenue Growth | 18.80% | Earnings | 2026-04-30 | ROA | 3.50% | ROE | — | ROIC | — |
| Gross Margin | 3.69% | Oper. Margin | 1.23% | Profit Margin | 0.68% | Shs Outstand | 235.32M | Shs Float | 234.85M | Short Float | 2.95% |
| Short Ratio | 3.10 | Short Interest | — | 52W High | 233.60 | 52W Low | 133.48 | Beta | 0.65 | Avg Volume | 1.73M |
| Volume | 2.52M | Target Price | $248.27 | Recom | Strong_buy | Prev Close | $204.92 | Price | $200.55 | Change | -2.13% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-08 | main | Evercore ISI Group | Outperform → Outperform | $240 |
| 2026-02-24 | main | Barclays | Overweight → Overweight | $258 |
| 2026-02-10 | main | JP Morgan | Neutral → Neutral | $243 |
| 2026-02-10 | main | Wells Fargo | Overweight → Overweight | $256 |
| 2026-02-06 | main | Mizuho | Outperform → Outperform | $235 |
| 2026-01-29 | main | Morgan Stanley | Overweight → Overweight | $245 |
| 2026-01-15 | main | Wells Fargo | Overweight → Overweight | $237 |
| 2026-01-09 | up | Citigroup | Neutral → Buy | $244 |
| 2025-12-09 | init | Barclays | — → Overweight | $243 |
| 2025-11-05 | main | Wells Fargo | Overweight → Overweight | $221 |
| 2025-11-04 | main | Mizuho | Outperform → Outperform | $210 |
| 2025-11-03 | main | TD Cowen | Buy → Buy | $225 |
| 2025-10-31 | main | Citigroup | Neutral → Neutral | $190 |
| 2025-10-31 | main | UBS | Buy → Buy | $220 |
| 2025-10-31 | main | Evercore ISI Group | Outperform → Outperform | $220 |
| 2025-08-13 | main | Wells Fargo | Overweight → Overweight | $185 |
| 2025-08-13 | main | Evercore ISI Group | Outperform → Outperform | $190 |
| 2025-08-13 | main | Baird | Outperform → Outperform | $203 |
| 2025-08-12 | main | Leerink Partners | Outperform → Outperform | $186 |
| 2025-07-16 | main | Morgan Stanley | Overweight → Overweight | $190 |
News
RSS: Latest CAH news- Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo! Finance Canada Wed, 22 Apr 2026 22
- Cardinal Health (CAH) stock moves -1.71%: What you should know - MSN Sun, 19 Apr 2026 15
- Cardinal Health Stock (CAH) Opinions on Recent Dividend Payout - Quiver Quantitative Fri, 17 Apr 2026 14
- Cardinal Health: Looking Into The Business Shift (NYSE:CAH) - Seeking Alpha ue, 21 Apr 2026 14
- CAH (Cardinal Health Inc.) Q1 2026 EPS exceeds estimates, slight year over year revenue decline pulls shares down 1.45 percent. - Core Business Growth - Xã Thanh Hà hu, 23 Apr 2026 02
- Cardinal Health Stock (CAH) Opinions on Recent Dividend Payout - Moomoo Fri, 17 Apr 2026 14
- Is Cardinal Health (CAH) Stock Undervalued Right Now? - qz.com ue, 07 Apr 2026 08
- New Cardinal Health (CAH) chair receives 381-share RSU equity grant - Stock Titan Fri, 17 Apr 2026 11
- Here's why Cardinal Health (CAH) is a strong momentum stock - MSN Wed, 22 Apr 2026 07
- Lobbying Update: $1,320,000 of CARDINAL HEALTH INC lobbying was just disclosed - Quiver Quantitative ue, 21 Apr 2026 03
- Here's Why Cardinal Health (CAH) is a Strong Value Stock - Yahoo Finance Wed, 22 Apr 2026 13
- Cancer drug developers get more Actinium-225 as Cardinal Health expands - Stock Titan Wed, 01 Apr 2026 07
- Here's Why Cardinal Health (CAH) is a Strong Momentum Stock - Yahoo Finance Mon, 20 Apr 2026 13
- Cardinal Health Stock (CAH) Opinions on Geopolitical Sell-Off and Leadership Shift - Quiver Quantitative Sat, 11 Apr 2026 14
- Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Wed, 15 Apr 2026 22
Insider Transactions
Financials
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
222,578.00
-1.87%
|
226,827.00
+10.66%
|
204,979.00
+13.04%
|
181,326.00
|
| Operating Revenue |
|
222,578.00
-1.87%
|
226,827.00
+10.66%
|
204,979.00
+13.04%
|
181,326.00
|
| Cost Of Revenue |
|
214,410.00
-2.28%
|
219,413.00
+10.76%
|
198,105.00
+13.31%
|
174,842.00
|
| Reconciled Cost Of Revenue |
|
214,084.00
-2.24%
|
218,987.00
+10.77%
|
197,698.00
+13.31%
|
174,474.00
|
| Gross Profit |
|
8,168.00
+10.17%
|
7,414.00
+7.86%
|
6,874.00
+6.01%
|
6,484.00
|
| Operating Expense |
|
5,846.00
+10.64%
|
5,284.00
+3.91%
|
5,085.00
+5.15%
|
4,836.00
|
| Selling General And Administration |
|
5,382.00
+7.64%
|
5,000.00
+4.17%
|
4,800.00
+6.38%
|
4,512.00
|
| Total Expenses |
|
220,256.00
-1.98%
|
224,697.00
+10.58%
|
203,190.00
+13.09%
|
179,678.00
|
| Operating Income |
|
2,322.00
+9.01%
|
2,130.00
+19.06%
|
1,789.00
+8.56%
|
1,648.00
|
| Total Operating Income As Reported |
|
2,275.00
+83.02%
|
1,243.00
+65.29%
|
752.00
+223.89%
|
-607.00
|
| EBITDA |
|
3,106.00
+58.31%
|
1,962.00
+36.34%
|
1,439.00
+2516.36%
|
55.00
|
| Normalized EBITDA |
|
3,153.00
+10.67%
|
2,849.00
+15.06%
|
2,476.00
+6.82%
|
2,318.00
|
| Reconciled Depreciation |
|
790.00
+11.27%
|
710.00
+2.60%
|
692.00
+0.00%
|
692.00
|
| EBIT |
|
2,316.00
+84.98%
|
1,252.00
+67.60%
|
747.00
+217.27%
|
-637.00
|
| Total Unusual Items |
|
-47.00
+94.70%
|
-887.00
+14.46%
|
-1,037.00
+54.18%
|
-2,263.00
|
| Total Unusual Items Excluding Goodwill |
|
-47.00
+94.70%
|
-887.00
+14.46%
|
-1,037.00
+54.18%
|
-2,263.00
|
| Special Income Charges |
|
-47.00
+94.70%
|
-887.00
+14.46%
|
-1,037.00
+54.18%
|
-2,263.00
|
| Other Special Charges |
|
-185.00
-337.18%
|
78.00
+125.66%
|
-304.00
-392.31%
|
104.00
|
| Impairment Of Capital Assets |
|
—
|
634.00
-49.12%
|
1,246.00
-39.51%
|
2,060.00
|
| Restructuring And Mergern Acquisition |
|
214.00
+22.29%
|
175.00
+84.21%
|
95.00
-5.94%
|
101.00
|
| Write Off |
|
18.00
-97.16%
|
634.00
-49.12%
|
1,246.00
|
—
|
| Net Income |
|
1,561.00
+83.22%
|
852.00
+158.18%
|
330.00
+135.18%
|
-938.00
|
| Pretax Income |
|
2,101.00
+74.94%
|
1,201.00
+81.15%
|
663.00
+184.57%
|
-784.00
|
| Net Non Operating Interest Income Expense |
|
-215.00
-321.57%
|
-51.00
+39.29%
|
-84.00
+42.86%
|
-147.00
|
| Interest Expense Non Operating |
|
215.00
+321.57%
|
51.00
-39.29%
|
84.00
-42.86%
|
147.00
|
| Net Interest Income |
|
-215.00
-321.57%
|
-51.00
+39.29%
|
-84.00
+42.86%
|
-147.00
|
| Interest Expense |
|
215.00
+321.57%
|
51.00
-39.29%
|
84.00
-42.86%
|
147.00
|
| Other Income Expense |
|
-6.00
+99.32%
|
-878.00
+15.74%
|
-1,042.00
+54.40%
|
-2,285.00
|
| Other Non Operating Income Expenses |
|
41.00
+355.56%
|
9.00
+280.00%
|
-5.00
+77.27%
|
-22.00
|
| Gain On Sale Of Business |
|
—
|
0.00
|
0.00
-100.00%
|
2.00
|
| Tax Provision |
|
532.00
+52.87%
|
348.00
+4.82%
|
332.00
+116.99%
|
153.00
|
| Tax Rate For Calcs |
|
0.00
-12.69%
|
0.00
+37.98%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-11.89
+95.37%
|
-257.02
-18.02%
|
-217.77
+54.18%
|
-475.23
|
| Net Income Including Noncontrolling Interests |
|
1,569.00
+83.94%
|
853.00
+157.70%
|
331.00
+135.33%
|
-937.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
1,561.00
+83.22%
|
852.00
+158.18%
|
330.00
+135.18%
|
-938.00
|
| Net Income From Continuing And Discontinued Operation |
|
1,561.00
+83.22%
|
852.00
+158.18%
|
330.00
+135.18%
|
-938.00
|
| Net Income Continuous Operations |
|
1,569.00
+83.94%
|
853.00
+157.70%
|
331.00
+135.33%
|
-937.00
|
| Minority Interests |
|
-8.00
-700.00%
|
-1.00
+0.00%
|
-1.00
+0.00%
|
-1.00
|
| Normalized Income |
|
1,596.11
+7.70%
|
1,481.98
+28.95%
|
1,149.23
+35.24%
|
849.77
|
| Net Income Common Stockholders |
|
1,561.00
+83.22%
|
852.00
+158.18%
|
330.00
+135.18%
|
-938.00
|
| Diluted EPS |
|
6.45
+86.96%
|
3.45
+245.00%
|
1.00
+129.85%
|
-3.35
|
| Basic EPS |
|
6.48
+86.21%
|
3.48
+248.00%
|
1.00
+129.85%
|
-3.35
|
| Basic Average Shares |
|
241.00
-1.63%
|
245.00
-6.13%
|
261.00
-6.45%
|
279.00
|
| Diluted Average Shares |
|
242.00
-2.02%
|
247.00
-5.73%
|
262.00
-6.09%
|
279.00
|
| Diluted NI Availto Com Stockholders |
|
1,561.00
+83.22%
|
852.00
+158.18%
|
330.00
+135.18%
|
-938.00
|
| Amortization |
|
464.00
+63.38%
|
284.00
-0.35%
|
285.00
-12.04%
|
324.00
|
| Amortization Of Intangibles Income Statement |
|
464.00
+63.38%
|
284.00
-0.35%
|
285.00
-12.04%
|
324.00
|
| Depreciation Amortization Depletion Income Statement |
|
464.00
+63.38%
|
284.00
-0.35%
|
285.00
-12.04%
|
324.00
|
| Depreciation And Amortization In Income Statement |
|
464.00
+63.38%
|
284.00
-0.35%
|
285.00
-12.04%
|
324.00
|
| Gain On Sale Of PPE |
|
—
|
-634.00
+49.28%
|
-1,250.00
+39.32%
|
-2,060.00
|
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets |
|
53,122.00
+17.73%
|
45,121.00
+4.09%
|
43,349.00
-1.21%
|
43,878.00
|
| Current Assets |
|
36,373.00
+4.27%
|
34,884.00
+3.40%
|
33,737.00
+2.44%
|
32,935.00
|
| Cash Cash Equivalents And Short Term Investments |
|
3,874.00
-24.53%
|
5,133.00
+25.93%
|
4,076.00
-13.59%
|
4,717.00
|
| Cash And Cash Equivalents |
|
3,874.00
-24.53%
|
5,133.00
+25.93%
|
4,076.00
-13.59%
|
4,717.00
|
| Receivables |
|
13,242.00
+9.58%
|
12,084.00
+8.79%
|
11,108.00
+5.18%
|
10,561.00
|
| Accounts Receivable |
|
13,242.00
+9.58%
|
12,084.00
+8.79%
|
11,108.00
+5.18%
|
10,561.00
|
| Gross Accounts Receivable |
|
13,455.00
+9.24%
|
12,317.00
+8.54%
|
11,348.00
+4.74%
|
10,834.00
|
| Allowance For Doubtful Accounts Receivable |
|
-213.00
+8.58%
|
-233.00
+2.92%
|
-240.00
+12.09%
|
-273.00
|
| Inventory |
|
16,831.00
+12.53%
|
14,957.00
-7.21%
|
16,119.00
+3.09%
|
15,636.00
|
| Prepaid Assets |
|
—
|
—
|
2,362.00
+16.87%
|
2,021.00
|
| Assets Held For Sale Current |
|
12.00
-74.47%
|
47.00
-66.43%
|
140.00
|
0.00
|
| Other Current Assets |
|
2,414.00
-9.35%
|
2,663.00
+16.09%
|
2,294.00
+13.51%
|
2,021.00
|
| Total Non Current Assets |
|
16,749.00
+63.61%
|
10,237.00
+6.50%
|
9,612.00
-12.16%
|
10,943.00
|
| Net PPE |
|
2,858.00
+13.01%
|
2,529.00
+2.76%
|
2,461.00
+4.24%
|
2,361.00
|
| Gross PPE |
|
7,516.00
+12.26%
|
6,695.00
+6.10%
|
6,310.00
+7.26%
|
5,883.00
|
| Accumulated Depreciation |
|
-4,658.00
-11.81%
|
-4,166.00
-8.24%
|
-3,849.00
-9.28%
|
-3,522.00
|
| Properties |
|
2,178.00
+15.91%
|
1,879.00
+5.03%
|
1,789.00
+3.77%
|
1,724.00
|
| Land And Improvements |
|
—
|
—
|
1,785.00
+3.54%
|
1,724.00
|
| Machinery Furniture Equipment |
|
4,761.00
+12.31%
|
4,239.00
+5.84%
|
4,005.00
+5.37%
|
3,801.00
|
| Construction In Progress |
|
577.00
+0.00%
|
577.00
+11.82%
|
516.00
+44.13%
|
358.00
|
| Goodwill And Other Intangible Assets |
|
12,177.00
+88.79%
|
6,450.00
+6.00%
|
6,085.00
-20.24%
|
7,629.00
|
| Goodwill |
|
9,269.00
+96.17%
|
4,725.00
+2.43%
|
4,613.00
-21.21%
|
5,855.00
|
| Other Intangible Assets |
|
2,908.00
+68.58%
|
1,725.00
+17.19%
|
1,472.00
-17.02%
|
1,774.00
|
| Other Non Current Assets |
|
1,714.00
+36.25%
|
1,258.00
+18.01%
|
1,066.00
+11.86%
|
953.00
|
| Total Liabilities Net Minority Interest |
|
55,756.00
+15.36%
|
48,333.00
+4.38%
|
46,306.00
+3.86%
|
44,584.00
|
| Current Liabilities |
|
38,897.00
+9.14%
|
35,640.00
+5.63%
|
33,740.00
+10.44%
|
30,550.00
|
| Payables And Accrued Expenses |
|
38,347.00
+8.92%
|
35,206.00
+6.99%
|
32,906.00
+9.80%
|
29,970.00
|
| Payables |
|
34,713.00
+9.30%
|
31,759.00
+6.10%
|
29,934.00
+10.34%
|
27,128.00
|
| Accounts Payable |
|
34,713.00
+9.30%
|
31,759.00
+6.10%
|
29,934.00
+10.34%
|
27,128.00
|
| Current Accrued Expenses |
|
3,634.00
+5.43%
|
3,447.00
+15.98%
|
2,972.00
+4.57%
|
2,842.00
|
| Current Debt And Capital Lease Obligation |
|
550.00
+26.73%
|
434.00
-45.20%
|
792.00
+36.55%
|
580.00
|
| Current Debt |
|
550.00
+26.73%
|
434.00
-45.20%
|
792.00
+36.55%
|
580.00
|
| Other Current Liabilities |
|
—
|
—
|
42.00
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
16,859.00
+32.82%
|
12,693.00
+1.01%
|
12,566.00
-10.46%
|
14,034.00
|
| Long Term Debt And Capital Lease Obligation |
|
7,977.00
+71.25%
|
4,658.00
+19.16%
|
3,909.00
-17.44%
|
4,735.00
|
| Long Term Debt |
|
7,977.00
+71.25%
|
4,658.00
+19.16%
|
3,909.00
-17.44%
|
4,735.00
|
| Non Current Deferred Liabilities |
|
—
|
—
|
8,653.00
-6.95%
|
9,299.00
|
| Non Current Deferred Taxes Liabilities |
|
—
|
—
|
8,653.00
-6.95%
|
9,299.00
|
| Other Non Current Liabilities |
|
8,882.00
+10.54%
|
8,035.00
-7.18%
|
8,657.00
-6.90%
|
9,299.00
|
| Stockholders Equity |
|
-2,781.00
+13.45%
|
-3,213.00
-8.62%
|
-2,958.00
-317.21%
|
-709.00
|
| Common Stock Equity |
|
-2,781.00
+13.45%
|
-3,213.00
-8.62%
|
-2,958.00
-317.21%
|
-709.00
|
| Capital Stock |
|
2,956.00
+1.34%
|
2,917.00
+6.23%
|
2,746.00
-2.38%
|
2,813.00
|
| Common Stock |
|
2,956.00
+1.34%
|
2,917.00
+6.23%
|
2,746.00
-2.38%
|
2,813.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
270.68
-17.22%
|
327.00
+0.00%
|
327.00
+0.00%
|
327.00
|
| Ordinary Shares Number |
|
238.68
-2.18%
|
244.00
-2.79%
|
251.00
-8.06%
|
273.00
|
| Treasury Shares Number |
|
32.00
-61.45%
|
83.00
+9.21%
|
76.00
+40.74%
|
54.00
|
| Retained Earnings |
|
783.00
+373.78%
|
-286.00
+55.45%
|
-642.00
-129.29%
|
-280.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-155.00
+7.19%
|
-167.00
-10.60%
|
-151.00
-32.46%
|
-114.00
|
| Treasury Stock |
|
6,365.00
+12.12%
|
5,677.00
+15.60%
|
4,911.00
+57.00%
|
3,128.00
|
| Minority Interest |
|
147.00
+14600.00%
|
1.00
+0.00%
|
1.00
-66.67%
|
3.00
|
| Other Equity Adjustments |
|
-155.00
+7.19%
|
-167.00
-10.60%
|
-151.00
-32.46%
|
-114.00
|
| Total Equity Gross Minority Interest |
|
-2,634.00
+18.00%
|
-3,212.00
-8.62%
|
-2,957.00
-318.84%
|
-706.00
|
| Total Capitalization |
|
5,196.00
+259.58%
|
1,445.00
+51.95%
|
951.00
-76.38%
|
4,026.00
|
| Working Capital |
|
-2,524.00
-233.86%
|
-756.00
-25100.00%
|
-3.00
-100.13%
|
2,385.00
|
| Invested Capital |
|
5,746.00
+205.80%
|
1,879.00
+7.80%
|
1,743.00
-62.16%
|
4,606.00
|
| Total Debt |
|
8,527.00
+67.46%
|
5,092.00
+8.32%
|
4,701.00
-11.55%
|
5,315.00
|
| Net Debt |
|
4,653.00
|
—
|
625.00
+4.52%
|
598.00
|
| Net Tangible Assets |
|
-14,958.00
-54.80%
|
-9,663.00
-6.86%
|
-9,043.00
-8.46%
|
-8,338.00
|
| Tangible Book Value |
|
-14,958.00
-54.80%
|
-9,663.00
-6.86%
|
-9,043.00
-8.46%
|
-8,338.00
|
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
2,397.00
-36.28%
|
3,762.00
+32.28%
|
2,844.00
-10.43%
|
3,175.00
|
| Cash Flow From Continuing Operating Activities |
|
2,397.00
-36.28%
|
3,762.00
+32.28%
|
2,844.00
-10.43%
|
3,175.00
|
| Net Income From Continuing Operations |
|
1,569.00
+83.94%
|
853.00
+157.70%
|
331.00
+135.33%
|
-937.00
|
| Depreciation Amortization Depletion |
|
790.00
+11.27%
|
710.00
+2.60%
|
692.00
+0.00%
|
692.00
|
| Depreciation And Amortization |
|
790.00
+11.27%
|
710.00
+2.60%
|
692.00
+0.00%
|
692.00
|
| Stock Based Compensation |
|
244.00
+101.65%
|
121.00
+26.04%
|
96.00
+18.52%
|
81.00
|
| Provisionand Write Offof Assets |
|
53.00
+47.22%
|
36.00
-34.55%
|
55.00
+139.13%
|
23.00
|
| Asset Impairment Charge |
|
21.00
-96.70%
|
636.00
-49.24%
|
1,253.00
-39.88%
|
2,084.00
|
| Deferred Tax |
|
243.00
+333.65%
|
-104.00
-160.00%
|
-40.00
-385.71%
|
14.00
|
| Deferred Income Tax |
|
243.00
+333.65%
|
-104.00
-160.00%
|
-40.00
-385.71%
|
14.00
|
| Operating Gains Losses |
|
—
|
—
|
—
|
8.00
|
| Change In Working Capital |
|
-523.00
-134.64%
|
1,510.00
+230.42%
|
457.00
-62.23%
|
1,210.00
|
| Change In Receivables |
|
-833.00
+16.37%
|
-996.00
-4.84%
|
-950.00
+32.38%
|
-1,405.00
|
| Changes In Account Receivables |
|
-833.00
+16.37%
|
-996.00
-4.84%
|
-950.00
+32.38%
|
-1,405.00
|
| Change In Inventory |
|
-1,816.00
-262.87%
|
1,115.00
+370.63%
|
-412.00
+65.78%
|
-1,204.00
|
| Change In Payables And Accrued Expense |
|
2,126.00
+52.84%
|
1,391.00
-23.53%
|
1,819.00
-52.37%
|
3,819.00
|
| Change In Accrued Expense |
|
-606.00
-39.95%
|
-433.00
+56.57%
|
-997.00
-477.65%
|
264.00
|
| Change In Payable |
|
2,732.00
+49.78%
|
1,824.00
-35.23%
|
2,816.00
-20.79%
|
3,555.00
|
| Change In Account Payable |
|
2,732.00
+49.78%
|
1,824.00
-35.23%
|
2,816.00
-20.79%
|
3,555.00
|
| Investing Cash Flow |
|
-5,593.00
-202.49%
|
-1,849.00
-307.27%
|
-454.00
-180.07%
|
567.00
|
| Cash Flow From Continuing Investing Activities |
|
-5,593.00
-202.49%
|
-1,849.00
-307.27%
|
-454.00
-180.07%
|
567.00
|
| Net PPE Purchase And Sale |
|
-547.00
-7.05%
|
-511.00
-6.24%
|
-481.00
-35.11%
|
-356.00
|
| Purchase Of PPE |
|
-547.00
-7.05%
|
-511.00
-6.24%
|
-481.00
-24.29%
|
-387.00
|
| Sale Of PPE |
|
—
|
12.00
+0.00%
|
12.00
-61.29%
|
31.00
|
| Capital Expenditure |
|
-547.00
-7.05%
|
-511.00
-6.24%
|
-481.00
-24.29%
|
-387.00
|
| Net Investment Purchase And Sale |
|
202.00
+221.69%
|
-166.00
-672.41%
|
29.00
+31.82%
|
22.00
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-550.00
|
0.00
+100.00%
|
-78.00
|
| Sale Of Investment |
|
202.00
-47.40%
|
384.00
+1224.14%
|
29.00
-71.00%
|
100.00
|
| Net Business Purchase And Sale |
|
-5,250.00
-341.18%
|
-1,190.00
-11800.00%
|
-10.00
-101.11%
|
901.00
|
| Purchase Of Business |
|
-5,250.00
-341.18%
|
-1,190.00
-11800.00%
|
-10.00
+54.55%
|
-22.00
|
| Gain Loss On Sale Of Business |
|
—
|
0.00
|
0.00
+100.00%
|
-2.00
|
| Net Other Investing Changes |
|
2.00
-88.89%
|
18.00
+125.00%
|
8.00
|
—
|
| Financing Cash Flow |
|
1,940.00
+329.04%
|
-847.00
+72.24%
|
-3,051.00
-23.87%
|
-2,463.00
|
| Cash Flow From Continuing Financing Activities |
|
1,940.00
+329.04%
|
-847.00
+72.24%
|
-3,051.00
-23.87%
|
-2,463.00
|
| Net Issuance Payments Of Debt |
|
3,224.00
+805.62%
|
356.00
+161.49%
|
-579.00
+34.58%
|
-885.00
|
| Issuance Of Debt |
|
3,669.00
+222.12%
|
1,139.00
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-445.00
+43.17%
|
-783.00
-35.23%
|
-579.00
+34.58%
|
-885.00
|
| Long Term Debt Issuance |
|
3,669.00
+222.12%
|
1,139.00
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-445.00
+43.17%
|
-783.00
-35.23%
|
-579.00
+34.58%
|
-885.00
|
| Net Long Term Debt Issuance |
|
3,224.00
+805.62%
|
356.00
+161.49%
|
-579.00
+34.58%
|
-885.00
|
| Net Short Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Net Common Stock Issuance |
|
-765.00
-2.00%
|
-750.00
+62.50%
|
-2,000.00
-100.00%
|
-1,000.00
|
| Common Stock Payments |
|
-765.00
-2.00%
|
-750.00
+62.50%
|
-2,000.00
-100.00%
|
-1,000.00
|
| Common Stock Dividend Paid |
|
-494.00
+1.00%
|
-499.00
+4.95%
|
-525.00
+6.08%
|
-559.00
|
| Cash Dividends Paid |
|
-494.00
+1.00%
|
-499.00
+4.95%
|
-525.00
+6.08%
|
-559.00
|
| Repurchase Of Capital Stock |
|
-765.00
-2.00%
|
-750.00
+62.50%
|
-2,000.00
-100.00%
|
-1,000.00
|
| Net Other Financing Charges |
|
-25.00
-154.35%
|
46.00
-13.21%
|
53.00
+378.95%
|
-19.00
|
| Changes In Cash |
|
-1,256.00
-217.82%
|
1,066.00
+261.27%
|
-661.00
-151.68%
|
1,279.00
|
| Effect Of Exchange Rate Changes |
|
-3.00
+66.67%
|
-9.00
-12.50%
|
-8.00
+68.00%
|
-25.00
|
| Beginning Cash Position |
|
5,133.00
+25.93%
|
4,076.00
-14.10%
|
4,745.00
+40.30%
|
3,382.00
|
| End Cash Position |
|
3,874.00
-24.53%
|
5,133.00
+25.93%
|
4,076.00
-14.10%
|
4,745.00
|
| Free Cash Flow |
|
1,850.00
-43.09%
|
3,251.00
+37.58%
|
2,363.00
-15.24%
|
2,788.00
|
| Interest Paid Supplemental Data |
|
315.00
+47.20%
|
214.00
+5.42%
|
203.00
+32.68%
|
153.00
|
| Income Tax Paid Supplemental Data |
|
444.00
+132.46%
|
191.00
+22.44%
|
156.00
|
—
|
| Earnings Losses From Equity Investments |
|
—
|
—
|
—
|
—
|
| Other Cash Adjustment Outside Changein Cash |
|
—
|
0.00
|
0.00
-100.00%
|
109.00
|
| Sale Of Business |
|
—
|
9.00
|
0.00
-100.00%
|
923.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-17 View
- 8-K2026-03-23 View
- 8-K2026-03-05 View
- 42026-03-03 View
- 42026-02-18 View
- 42026-02-10 View
- 10-Q2026-02-05 View
- 8-K2026-02-05 View
- 42026-01-20 View
- 8-K2026-01-13 View
- 42025-12-02 View
- 42025-12-02 View
- 42025-12-02 View
- 42025-12-02 View
- 42025-12-02 View
- 42025-11-06 View
- 42025-11-06 View
- 42025-11-06 View
- 42025-11-06 View
- 42025-11-06 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|